Repeated procedures in the same children are not equivalent to the same number of independent participants.
What the publication shows
The retrospective study involved twenty-four children and 103 procedures using propofol after midazolam or dexmedetomidine premedication. Dexmedetomidine was associated with lower propofol requirements but longer wake-up times. Adverse events were reported as uncommon in both regimens.
Limits of the evidence
Treatment was not randomized, and repeated observations came from a small patient group. Procedure type, disease course and timing can influence dose requirements. Lower propofol use is not itself proof of neuroprotection or better overall recovery.
Application to expert review
For reviewing sedation evidence, retain both the patient count and procedure count. Compare recovery burden as well as dose sparing, and ask how repeated measurements were handled. The cohort does not establish a universal advantage over midazolam for every child undergoing oncology procedures.
Source and related reading
Source: Publication PMC12311750. The case-review applications above are interpretive analysis.
Related reading: A Pediatric Seizure-Infusion Commentary Should Not Be Counted as a Second Cohort.
Leave a Reply